Entry of Ebola Virus is an Asynchronous Process
|
|
- Horace Henderson
- 6 years ago
- Views:
Transcription
1 SUPPLEMENT ARTICLE Entry of Ebola Virus is an Asynchronous Process Olivier Reynard and Viktor E. Volchkov Laboratory Molecular Basis of Viral Pathogenicity, International Centre for Research in Infectiology (CIRI), INSERM U1111, Université de Lyon, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, France Ebola virus (EBOV) is responsible for a severe fever with a high mortality rate. The diverse nature of the attachment of the virus to the cell surface, the initial step of virus entry, raises questions concerning the kinetics of the virus internalization process. We investigated EBOV entry kinetics using the activity of a particular monoclonal antibody that neutralizes virus infectivity. We demonstrate that inoculation of cells with EBOV results in an asynchronous entry process, as revealed by the ability of the virus to remain in a cell-bound state for an extended period of time before it is internalized. Keywords. Ebola virus; family Filoviridae; glycoprotein GP; virus attachment; virus neutralizing antibody; virus entry kinetics. Ebola virus (EBOV) causes a severe form of hemorrhagic fever in humans and nonhuman primates [1]. EBOV is member of the family Filoviridae, a group of enveloped, nonsegmented, negative-strand RNA viruses [2]. The EBOV genome is about 19 kb long, containing 7 linearly arranged genes that program the expression of 7 structural and 3 nonstructural proteins [3 6]. The surface glycoprotein GP mediates virus attachment and entry into host cells. [7 10]. The GP molecule is highly glycosylated, with both N- and O-linked glycans. GP is cleaved by the cellular protease furin to generate a disulfide-linked GP 1 -GP 2 heterodimer [11]. The virion spikes are assembled as a trimer of the GP 1 -GP 2 molecules. It is generally accepted that viral cell entry occurs through virus attachment to the cell surface, followed by endocytosis (macropinocytosis or clathrin-mediated endocytosis; reviewed elsewhere [12]). After internalization, the GP undergo a proteolytic digestion at acid ph by cellular proteases cathepsin B and cathepsin L [7], leading to subsequent liberation of the receptor binding domain that interacts with an intracellular receptor, the Niemann Pick C1 protein (NPC1), an endosomal/ Correspondence: Viktor E. Volchkov, PhD, Laboratory Molecular Basis of Viral Pathogenicity, International Centre for Research in Infectiology, INSERM U1111, UCBL1, 21 Ave Tony Garnier, Lyon Cedex 07, France (viktor.volchkov@ inserm.fr). The Journal of Infectious Diseases 2015;212:S The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please journals.permissions@oup.com. DOI: /infdis/jiv189 lysosomal transporter of cholesterol [13]. Conformational rearrangements associated with the interaction between NPC1 and the cleaved GP are believed to result in exposure of a fusion loop that facilitates membrane fusion and the liberation of the viral nucleocapsid into the cell cytoplasm [14]. A significant part of surface GP is released from virus-infected cells owing to cleavage by the cellular metalloprotease TACE/ADAM17, giving rise to a soluble form of surface GP known as shed GP, which seems to play an important role in virus pathogenicity [15, 16]. The attachment of virions to the cell surface relies on a wide range of lectins (eg, dendritic cell specific intercellular adhesion molecule 3 grabbing nonintegrin [DC-SIGN], DC-SIGN homologue [DC-SIGN-R], Liver and limph node Sinusoidal Endothelial C Type Lectin [LSECTin], and folate receptor α) that recognize EBOV GP, and, in particular, its atypical and high glycosylation pattern [17 19]. There is also evidence for GP-nonspecific attachment of EBOV via phosphatidylserine molecules present in the virion membrane and cell surface T cell/transmembrane, immunoglobulin, and mucin (TIM) and Tyro3, Axl, Mer (TAM) family receptor [20 22]. In the current study, we investigated EBOV entry kinetics using the activity of a particular monoclonal antibody (mab) that neutralizes virus infectivity. We demonstrated that inoculation of cells with EBOV results in an asynchronous entry process, as revealed by the ability of the virus to remain in a cell-bound state for an extended period of time before it is internalized. Ebola Virus Entry Kinetics JID 2015:212 (Suppl 2) S199
2 MATERIALS AND METHODS Viruses, Cells, and Reagents Recombinant Zaire ebolavirus, strain Mayinga, expressing green fluorescent protein (EBOV-GFP) was generated as described elsewhere [23] and used for infection of Vero E6, Huh7, and EpoNi cells, a bat (Epomops franqueti) kidney derived cell line [24]. Cells were cultured at 37 C in Dulbecco s modified Eagle s medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum (FCS). Experiments using EBOV were performed in the BSL4 INSERM Laboratory Jean Mérieux. Reynard et al [25] have presented data on a panel of 87 mabs directed against Ebola virus GP. One mab in the panel, mab 3327, displayed strong virus-neutralizing activity (O. Reynard and V. Volchkov, unpublished data). This mab was produced in CD hybridoma medium (Life Technologies) and purified with protein G sepharose affinity chromatography (GE Healthcare). Kinetic Assay and Flow Cytometry EBOV-GFP was used to inoculate Vero E6, Huh7, or EpoNi cells at a multiplicity of infection of 0.5 in 24-well plates, using 0.3 ml of inoculum. After incubation for 1 hour at 37 C, virus was removed and cells were washed twice with 1 ml of DMEM before the addition of DMEM 3% FCS. At time 0, cells were inoculated with a mix of the virus and mab 3327 for 48 hours. At 1, 2, 4, and 6 hours after inoculation, DMEM 3% FCS was replaced by medium containing 10 µg/ml of mab 3327, leading to neutralization of cell-bound virions. Cells were trypsinized and analyzed using flow cytometry performed with a Beckman Gallios instrument 48 hours after infection. All experiments were performed in triplicate. of the initial attachment step raises questions concerning the kinetics of the virus internalization process. To address these questions, we used a recently described neutralizing antibody, referred to here as mab 3327, which neutralizes virus particles at a late step of virus entry, presumably before membrane fusion but after GP cleavage by cellular cathepsins and interaction with NPC1 (O. Reynard and V. Volchkov, unpublished data). This mode of action implies that the antibody is able to bind virus particles and is then internalized along with the virion. In this sense, virions that are internalized before antibody binding are no longer susceptible to its neutralization action. We were thus able to monitor the kinetics of the viral internalization process by adding this antibody at different time points after the removal of the viral inoculum. In the experiment shown in Figure 1, mab 3327 was added to Vero E6 cells either simultaneous with the virus at time 0 or at different time points up to 6 hours after inoculation with a recombinant EBOV expressing GFP (EBOV-GFP). After 48 hours of growth in medium containing 10 µg/ml mab 3327, the number of infected cells was measured by counting GFPpositive cells using flow cytometry. In this manner, we were able to evaluate the number of cells infected at the different time points and before the administration of neutralizing antibodies. Culturing of infected cells in the presence of mab allows us to avoid possible difficulties in interpreting the results related to release of virus from the cells and subsequent second-round infection. Of note, at 6 hours after inoculation in this assay setup, we consider that we can no longer discriminate between infection coming from the initial inoculation and that arising from newly Plaque Assay Subconfluent Vero E6 cells in 6-well plates were infected with serial dilutions of EBOV-GFP. After 1-hour incubation, the inoculum was removed, and the cells were overlaid with 0.4% agar containing DMEM 3% FCS. Plates were incubated for 72 hours at 37 C and then subjected to imaging under a Nikon UV macroscope (Multizoom AZ1100). Plaque size (fluorescent area) was measured using ImageJ software (version 1.46R, National Institutes of Health) [26]. RESULTS AND DISCUSSION EBOV entry is a multistep process that begins with attachment of virus particles to the cell surface. Several cellular factors DC-SIGN/liver/lymph node-specific intracellular adhesion molecules-3 grabbing non-integrin, LSECtin, human macrophage galactose- and N-acetylgalactosamine-specific C-type lectin, β-integrins, and Tyro3 family receptors have been proposed to play a role in virus attachment and could explain the pantropic character of EBOV infection [12]. The diverse nature Figure 1. Kinetics of Ebola virus (EBOV) entry. Kinetics of EBOV entry were analyzed using the ability of monoclonal antibody (mab) 3327 to neutralize virus attached to the cell surface. Three cell lines were used (EpoNi, Huh7, and Vero E6), and mab 3327 was added to the cells at different times up to 6 hours after inoculation with EBOV expressing green fluorescent protein (GFP). After 48 hours of growth in medium containing 10 µg/ ml mab 3327, the number of infected cells was measured by counting GFP-positive cells, using flow cytometry. Thus, the number of cells infected at the different time points and before the administration of neutralizing antibodies was evaluated. All results are shown normalized to levels seen for time point 6 hours after infection for each cell type. Data represent mean values from 3 independent experiments. S200 JID 2015:212 (Suppl 2) Olivier and Volchkov
3 Figure 2. Heterogeneity in Ebola virus (EBOV) plaque size. EBOV plaques are unusually heterogeneous in size on agar-overlaid Vero E6 cells. A, Two examples of small and large plaques formed by EBOV-GFP. B, Six plaque-isolated viral clones, either small (S) (<100 µm) or large (L) (>800 µm) in diameter at passage 0, were amplified in Vero E6 cells and then subjected to analysis of plaque size. Left, Variation in plaque size for this second passage is shown as a mean and standard deviation for each selected viral clone. Right, Variation in plaque size for initially selected groups of either small- or large-plaque viral isolates is shown as the range of the mean (boxes), the median (middle line), and the mean of their standard deviation (whiskers). C, A third round of selection of EBOV viral clones for plaque size was performed for a number of both large- and small-plaque clones, and data are shown as described above. LL and SS represent clones for which a large- or small-plaque clone, respectively, was selected at both passage 0 and passage 1; LS, clones for which a large-plaque clone was selected at passage 0 and a small-plaque clone at passage 1; and SL, clones for which a small-plaque clone was selected at passage 0 and a large-plaque clone at passage 1. Right, No significant differences in plaque size distribution were found for any group. released virions. To compare cell lines, all results are shown normalized to levels seen for time point 6 hours after infection. As shown in Figure 1, for certain cell lines a surprising number of EBOV particles seem to be not yet internalized at 4 hours. It is also apparent that internalization seems to be a clearly asynchronous process. As measured by the entry kinetics shown in Figure 1, internalization in Huh7 cells seems to require even longer than in Vero E6 cells. In sharp contrast, for a cell line derived from the kidney of the bat E. franqueti, a suggested natural reservoir of EBOV, the virus entry process is extremely fast, and most particles are internalized in a more synchronized manner. These results show that, in this setup, diverse cell types or cells of different origins clearly differ in terms of the kinetics of EBOV entry, in particular, virus internalization. The observed differences in entry kinetics are most likely multifactorial and can obviously implicate both the density and Ebola Virus Entry Kinetics JID 2015:212 (Suppl 2) S201
4 specificity of surface attachment molecules or the propensity of a cell type for macropinocytosis. Importantly, the data presented here clearly indicate that adherence of virions at 37 C is followed by an asynchronous process, with cells internalizing infectious particles from within a few minutes after inoculation to at least several hours later. That some particles can be very rapidly internalized after attachment to target cells is also illustrated by data in Figure 1 showing that, even for cells inoculated in the presence of antibody (time point 0), a number of particles are internalized before mab 3327 interacts to neutralize the virus. In this regard, our observations are consistent with those of several studies showing that at least some particles are quickly internalized at 37 C after an adhesion step at 4 C [27, 28]. It is interesting to speculate what is happening with viral particles after they attach to cells but are not yet internalized. It is plausible that, with a low concentration of attachment molecules on the cell surface and/or low affinity, viral particles can temporally detach from the cell surface before reattaching, in a mechanism that thus would allow a scanning of the cell surface for a better place to stably attach. Alternatively, this may also allow the virus to change target if the initial cell is not suitable for entry in some way. It could also allow virus to be delivered within the host from the initial site to a site of its replication, and such a mechanism might be important at the early stage of infection. Such transinfection as a way to spread within the host has been demonstrated for human immunodeficiency virus [29] and more recently for Nipah virus [30]. Therefore, a delay in virus internalization might not be as detrimental for the virus as it seems at first glance, and it might even provide some important advantages. This phenomenon probably also highlights the need for the viral particles to reach an area on the cell surface with sufficient concentration of adhesion factors to promote particle stabilization and internalization, and this sum of adhesion factors acting for particle stabilization is probably cell type specific. Of note, Vero E6 cells are not EBOV primary target cells, even though they are widely used to grow EBOV and many other viruses owing to defects in interferon production. In future experiments it will be important to also study virus entry kinetics using primary virus targets, and this work is currently ongoing. The asynchronous entry of EBOV into target cells could obviously be expected to have repercussions for the subsequent initiation of viral replication. Indeed, in cell culture, EBOV plaques were unusually heterogeneous in size on agar-overlaid Vero E6 cells. The differences in plaque size could therefore be explained by early or late internalization after attachment. If this hypothesis is true, one would not expect plaque size to be stable during clonal selection of plaques of different sizes. To test this idea, we analyzed the plaque size of EBOV-GFP and isolated several clones of plaques displaying either small or large diameters (Figure 2A). These clones were grown for 48 hours in Vero E6 cells and then analyzed again for plaque size. As shown in Figure 2B, plaques from all clones displayed a wide variety of sizes, as seen by the standard deviation between groups ( 35 plaques measured for each clone). When a second cloning step was performed, similar results were obtained, except for 2 clones that were found to induce permanently smaller diameter plaques (clones SS1 and SS6, with a small mean diameter and small standard deviation). It will be interesting to determine whether these 2 clones have any specific genotype with the appearance of stable mutations that might limit their growth. The appearance and subsequent selection of plaques showing a particular and specific phenotype (large plaque size) is known to be associated with EBOV/8U (variant containing 8 uridine residues at the GP gene editing site), which were selected during plaque purification [3 5]. The EBOV/8U variant was shown to have significant growth advantages over wild-type EBOV (EBOV/7U) in cell cultures. Although other factors (eg, cell cycle stage at the moment of virus entry) may also have an effect on EBOV plaque size heterogeneity, the data provided support the idea that the asynchronous and apparently substantially delayed entry of EBOV into target cells could explain this phenomenon. In conclusion, in this study we demonstrated that EBOV entry is an asynchronous process, as revealed by the property of the virus to remain in a cell-bound state for an extended period of time before it is internalized and then induce virus replication. Future studies will have to reveal the full significance of this delay in virus internalization during EBOV replication and the repercussions for this phenomenon within an infected host organism. Notes Acknowledgments. All experiments involving live EBOV were carried out in the INSERM BSL4 Laboratory Jean Mérieux in Lyon, France. We are grateful to staff of the SFR BioSciences cytometry platform of and to the INSERM BSL4 Jean Mérieux team members for technical assistance and support. We also thank Drs Philip Lawrence, Mathieu Mateo, and Xavier Carnec, International Centre for Research in Infectiology, Lyon, for helpful discussion and editing of the manuscript. Financial support. This work was supported by INSERM, Agence Nationale de la Recherche (grant ANR-07-MIME ), Fondation Pour la Recherche Médicale (grant DMI ), and European Union FP7 project ANTIGONE (grant ). Potential conflict of interest. Both authors: No reported conflicts. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. References 1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377: Kuhn JH, Becker S, Ebihara H, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010; 155: Sanchez A, Kiley MP, Holloway BP, Auperin DD. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 1993; 29: S202 JID 2015:212 (Suppl 2) Olivier and Volchkov
5 4. Volchkov VE, Becker S, Volchkova VA, et al. GP mrna of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995; 214: Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 2011; 204(suppl 3):S Volchkova VA, Klenk HD, Volchkov VE. Delta-peptide is the carboxyterminal cleavage fragment of the nonstructural small glycoprotein sgp of Ebola virus. Virology 1999; 265: Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308: Chan SY, Speck RF, Ma MC, Goldsmith MA. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 2000; 74: Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 1999; 73: Yang Z, Delgado R, Xu L, et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 1998; 279: Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 1998; 95: Hunt CL, Lennemann NJ, Maury W. Filovirus entry: a novelty in the viral fusion world. Viruses 2012; 4: Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011; 477: Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008; 454: Dolnik O, Volchkova V, Garten W, et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. Embo J 2004; 23: Escudero-Perez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog 2014; 10:e Chan SY, Empig CJ, Welte FJ, et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001; 106: Simmons G, Reeves JD, Grogan CC, et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003; 305: Powlesland AS, Fisch T, Taylor ME, et al. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 2008; 283: Jemielity S, Wang JJ, Chan YK, et al. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 2013; 9:e Brindley MA, Hunt CL, Kondratowicz AS, et al. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 2011; 415: Shimojima M, Takada A, Ebihara H, et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006; 80: Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE. Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis 2011; 204(suppl 3):S Hoffmann M, Muller MA, Drexler JF, et al. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. PLoS One 2013; 8:e Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 2009; 83: Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: Mingo RM, Simmons JA, Shoemaker CJ, et al. Ebola and SARS display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol 2015; 89: Aleksandrowicz P, Marzi A, Biedenkopf N, et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis 2011; 204(suppl 3):S Cavrois M, Neidleman J, Kreisberg JF, Greene WC. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 2007; 3:e Mathieu C, Pohl C, Szecsi J, et al. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol 2011; 85: Ebola Virus Entry Kinetics JID 2015:212 (Suppl 2) S203
Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity
SUPPLEMENT ARTICLE Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity Olga Dolnik, 1,2 Valentina A. Volchkova,
More informationEbola virus crisis. Prof. Viktor Volchkov. Molecular basis of viral pathogenicity
Ebola virus crisis Prof. Viktor Volchkov Molecular basis of viral pathogenicity International Centre for Research in Infectiology (CIRI), INSERM Claude Bernard University Lyon-1, Lyon, France viktor.volchkov@inserm.fr
More informationRole of Ebola Virus VP30 in Transcription Reinitiation
JOURNAL OF VIROLOGY, Dec. 2008, p. 12569 12573 Vol. 82, No. 24 0022-538X/08/$08.00 0 doi:10.1128/jvi.01395-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. Role of Ebola Virus
More informationEndosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection Kartik Chandran, 1 Nancy J. Sullivan, 2 Ute Felbor, 3 Sean P. Whelan, 4 James M. Cunningham 1,4 * 1 Department of Medicine,
More informationThe Ebola virus journey into the host cell Marceline Côté, Ph.D. Abstract Introduction
PostDoc Journal Vol. 1, No. 12, December 2013 Journal of Postdoctoral Research www.postdocjournal.com The Ebola virus journey into the host cell Marceline Côté, Ph.D. Department of Medicine, Brigham and
More informationDifferential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
Journal of General Virology (2000), 81, 2155 2159. Printed in Great Britain... SHORT COMMUNICATION Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
More informationaV. Code assigned:
This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the
More informationDistinct Mechanisms of Entry by Envelope Glycoproteins of Marburg and Ebola (Zaire) Viruses
JOURNAL OF VIROLOGY, May 2000, p. 4933 4937 Vol. 74, No. 10 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Distinct Mechanisms of Entry by Envelope Glycoproteins
More informationVirus Entry/Uncoating
Virus Entry/Uncoating Delivery of genome to inside of a cell Genome must be available for first step of replication The Problem--barriers to infection Virion Barriers: Non-enveloped viruses capsid Enveloped
More informationDepartment of Molecular Medicine, University of Padua, Via A. Gabelli 63, Padua, Italy
Short communication Amiodarone affects Ebola virus binding and entry into target cells Cristiano Salata 1, Denis Munegato 1, Francesco Martelli 1, Cristina Parolin 1, Arianna Calistri 1, Aldo Baritussio
More informationCoronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Coronaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Spherical enveloped particles studded with clubbed spikes Diameter 120-160 nm Coiled helical
More informationDr. Ahmed K. Ali Attachment and entry of viruses into cells
Lec. 6 Dr. Ahmed K. Ali Attachment and entry of viruses into cells The aim of a virus is to replicate itself, and in order to achieve this aim it needs to enter a host cell, make copies of itself and
More informationFilovirus Glycoprotein Sequence, Structure and Virulence
Filovirus Glycoprotein Sequence, Structure and Virulence J. C. Phillips Dept. of Physics and Astronomy, Rutgers University, Piscataway, N. J., Abstract Leading Ebola subtypes exhibit a wide mortality range,
More informationAttachment and Entry. Lecture 5 Biology W3310/4310 Virology Spring Who hath deceived thee so o-en as thyself? --BENJAMIN FRANKLIN
Attachment and Entry Lecture 5 Biology W3310/4310 Virology Spring 2016 Who hath deceived thee so o-en as thyself? --BENJAMIN FRANKLIN Viruses are obligate intracellular parasites Virus particles are too
More informationThe Ebola Virus. By Emilio Saavedra
The Ebola Virus By Emilio Saavedra Etiological Agents: Ebolavirus is the etiologic agent. [1] There are four main families of viruses that are agents of Ebola (hemorrhagic fever). [1] These four families
More informationInfluenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Influenza viruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped particles, quasi-spherical or filamentous Diameter 80-120 nm Envelope is derived
More informationQuantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles
Quantifying Lipid Contents in Enveloped Virus Particles with Plasmonic Nanoparticles Amin Feizpour Reinhard Lab Department of Chemistry and the Photonics Center, Boston University, Boston, MA May 2014
More informationVP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs
SUPPLEMENT ARTICLE VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs Mathieu Mateo, 1,a Caroline Carbonnelle, 1,2,a Olivier Reynard, 1 Larisa Kolesnikova, 3 Kirill Nemirov, 1 Audrey
More information19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics
9 Viruses CAMPBELL BIOLOGY TENTH EDITION Reece Urry Cain Wasserman Minorsky Jackson Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV Lecture Presentation
More informationVirus Entry. Steps in virus entry. Penetration through cellular membranes. Intracellular transport John Wiley & Sons, Inc. All rights reserved.
Virus Entry Steps in virus entry Penetration through cellular membranes Intracellular transport Steps in virus entry How do virions get into cells? Viruses of bacteria, archaea, algae and plants use different
More informationPart I What Is a Virus?
The Ebola Wars Advanced Edition Invincibility lies in the defense; the possibility of victory in the attack. Sun Tzu by Derek Dube, Department of Biology, University of Saint Joseph Linda M. Iadarola,
More informationIdentification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist
Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1
More informationLecture 2: Virology. I. Background
Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a
More informationBiochemical characterization of Ebola virus GP
University of Iowa Iowa Research Online Theses and Dissertations Spring 2014 Biochemical characterization of Ebola virus GP Nicholas Joseph Lennemann University of Iowa Copyright 2014 Nicholas Joseph Lennemann
More informationMEEGID XII. Ebola viruses: from the wild to humans
MEEGID XII Bangkok, 11-13 December 2014 Ebola viruses: from the wild to humans Jean-Claude Piffaretti Interlifescience, Massagno, Switzerland 1. Animal viruses jumping to humans 2. Influenza virus A 3.
More informationHost Cell Factors in Filovirus Entry: Novel Players, New Insights
Viruses 2012, 4, 3336-3362; doi:10.3390/v4123336 Review OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Host Cell Factors in Filovirus Entry: Novel Players, New Insights Heike Hofmann-Winkler
More informationGENERAL INTRODUCTION INTO THE EBOLA VIRUS BIOLOGY AND DISEASE
FOLIA MEDICA CRACOVIENSIA Vol. LIV, 3, 2014: 57 65 PL ISSN 0015-5616 57 Barbara Zawilińska 1, Magdalena Kosz-Vnenchak 1 GENERAL INTRODUCTION INTO THE EBOLA VIRUS BIOLOGY AND DISEASE Abstract: Epidemic
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationIN VIVO STUDIES ON VIRAL VIRULENCE
IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease
More informationReoviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Reoviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Naked icosahedral capsid (T=13), diameter 60-85 nm Capsid consists of two or three concentric protein
More informationnumber Done by Corrected by Doctor Ashraf
number 4 Done by Nedaa Bani Ata Corrected by Rama Nada Doctor Ashraf Genome replication and gene expression Remember the steps of viral replication from the last lecture: Attachment, Adsorption, Penetration,
More informationVIRAL AGENTS CAUSING GASTROENTERITIS
VIRAL AGENTS CAUSING GASTROENTERITIS VIRAL AGENTS CAUSING GASTROENTERITIS Pathogens discussed in our lectures 1. Rotavirus 2. Enteric adenoviruses 3. Caliciviruses 4. Astroviruses 5. Toroviruses Viruses
More informationFlu, Avian Flu and emerging aspects (H1N1 resistance)
EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory
More informationRAISON D ETRE OF THE IMMUNE SYSTEM:
RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Acquired Immunity Innate immunity: (Antigen nonspecific) defense
More informationCOURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12
COURSE: Medical Microbiology, MBIM 650/720 - Fall 2008 TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 FACULTY: Dr. Mayer Office: Bldg. #1, Rm B32 Phone: 733-3281 Email: MAYER@MED.SC.EDU
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationThe Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE
The Infectious Cycle Lecture 2 Biology W3310/4310 Virology Spring 2016 You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Virologists divide the infectious cycle into steps to facilitate
More informationPatricia Fitzgerald-Bocarsly
FLU Patricia Fitzgerald-Bocarsly October 23, 2008 Orthomyxoviruses Orthomyxo virus (ortho = true or correct ) Negative-sense RNA virus (complementary to mrna) Five different genera Influenza A, B, C Thogotovirus
More informationTitle. CitationBiochemical and biophysical research communications, Issue Date Doc URL. Type. File Information
Title A polymorphism of the TIM-1 IgV domain: Implications Kuroda, Makoto; Fujikura, Daisuke; Noyori, Osamu; Ka Author(s) Yoshida, Reiko; Takada, Ayato CitationBiochemical and biophysical research communications,
More information7.013 Spring 2005 Problem Set 7
MI Department of Biology 7.013: Introductory Biology - Spring 2005 Instructors: Professor Hazel Sive, Professor yler Jacks, Dr. Claudette Gardel 7.013 Spring 2005 Problem Set 7 FRIDAY May 6th, 2005 Question
More informationTITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More informationRAISON D ETRE OF THE IMMUNE SYSTEM:
RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Adaptive Immunity Innate immunity: (Antigen - nonspecific) defense
More information5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms
5/6/17 Disease Diseases I. II. Bacteria Viruses (including HIV) Biol 105 Chapter 13a Pathogens Pathogens are disease-causing organisms Domain Bacteria Characteristics 1. Domain Bacteria are prokaryotic.
More informationLESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
More informationImmunodeficiency. (2 of 2)
Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related
More informationLESSON 1.4 WORKBOOK. Viral sizes and structures. Workbook Lesson 1.4
Eukaryotes organisms that contain a membrane bound nucleus and organelles. Prokaryotes organisms that lack a nucleus or other membrane-bound organelles. Viruses small, non-cellular (lacking a cell), infectious
More information11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics
Chapter 19 - Viruses Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV II. Prions The Good the Bad and the Ugly Viruses fit into the bad category
More informationStructure and Function of Antigen Recognition Molecules
MICR2209 Structure and Function of Antigen Recognition Molecules Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will examine the major receptors used by cells of the innate and
More informationARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za
ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action
More informationUnit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS
1 Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS What steps are involved in viral infection and replication? Why are some kinds of influenza virus more deadly than others? How do flu
More informationnumbe r Done by Corrected by Doctor
numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationChapter 19: The Genetics of Viruses and Bacteria
Chapter 19: The Genetics of Viruses and Bacteria What is Microbiology? Microbiology is the science that studies microorganisms = living things that are too small to be seen with the naked eye Microorganisms
More informationbV. Code assigned:
This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the
More informationLESSON 1.4 WORKBOOK. Viral structures. Just how small are viruses? Workbook Lesson 1.4 1
Eukaryotes- organisms that contain a membrane bound nucleus and organelles Prokaryotes- organisms that lack a nucleus or other membrane-bound organelles Viruses-small acellular (lacking a cell) infectious
More informationMicrobiology 507. Immune Response to Pathogens. Topics in Molecular Pathogenesis and Immunology. Zakaria Hmama, PhD UBC - Department of Medicine
Microbiology 507 Topics in Molecular Pathogenesis and Immunology Immune Response to Pathogens Zakaria Hmama, PhD UBC - Department of Medicine October 2012 ecture 1 Mechanisms of HIV pathogenesis 1- History
More informationHIV-1 Virus-like Particle Budding Assay Nathan H Vande Burgt, Luis J Cocka * and Paul Bates
HIV-1 Virus-like Particle Budding Assay Nathan H Vande Burgt, Luis J Cocka * and Paul Bates Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
More informationSupplemental Information Dose Response Parameters for Gain of Function Pathogens
Supplemental Information Dose Response Parameters for Gain of Function Pathogens Infection Dose-Response To quantify the likelihood of an individual or animal becoming infected from exposure to virus,
More informationViral structure م.م رنا مشعل
Viral structure م.م رنا مشعل Viruses must reproduce (replicate) within cells, because they cannot generate energy or synthesize proteins. Because they can reproduce only within cells, viruses are obligate
More information8/13/2009. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Shapes. Domain Bacteria Characteristics
Disease Diseases I. Bacteria II. Viruses including Biol 105 Lecture 17 Chapter 13a are disease-causing organisms Domain Bacteria Characteristics 1. Domain Bacteria are prokaryotic 2. Lack a membrane-bound
More informationI. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission
Disease Diseases I. Bacteria II. Viruses including are disease-causing organisms Biol 105 Lecture 17 Chapter 13a Domain Bacteria Characteristics 1. Domain Bacteria are prokaryotic 2. Lack a membrane-bound
More informationChapter13 Characterizing and Classifying Viruses, Viroids, and Prions
Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions 11/20/2017 MDufilho 1 Characteristics of Viruses Viruses Minuscule, acellular, infectious agent having either DNA or RNA Cause infections
More informationThere are approximately 30,000 proteasomes in a typical human cell Each proteasome is approximately 700 kda in size The proteasome is made up of 3
Proteasomes Proteasomes Proteasomes are responsible for degrading proteins that have been damaged, assembled improperly, or that are of no profitable use to the cell. The unwanted protein is literally
More informationPROCEEDINGS OF THE FIFTII INTERNATIONAL SYMPOSIUM ON CORONAVIRUSES. Held September 13-18, 1992, in Chantilly France
PROCEEDINGS OF THE FIFTII INTERNATIONAL SYMPOSIUM ON CORONAVIRUSES Held September 13-18, 1992, in Chantilly France INDEX Adenovirus expression, ofprcv S protein, 469 oftgev S gene fragments, 455 A59 virus,
More informationImmunology - Lecture 2 Adaptive Immune System 1
Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers
More informationTransport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells
SUPPLEMENT ARTICLE Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells Gordian Schudt, Olga Dolnik, Larissa Kolesnikova,
More informationViral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP
Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationVIRUS TAXONOMY AND REPLICATION
VIRUS TAXONOMY AND REPLICATION Paulo Eduardo Brandão, PhD Department of Preventive Veterinary Medicine and Animal Health School of Veterinary Medicine University of São Paulo, Brazil I. VIRUS STRUCTURE
More informationSize nm m m
1 Viral size and organization Size 20-250nm 0.000000002m-0.000000025m Virion structure Capsid Core Acellular obligate intracellular parasites Lack organelles, metabolic activities, and reproduction Replicated
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationPolyomaviridae. Spring
Polyomaviridae Spring 2002 331 Antibody Prevalence for BK & JC Viruses Spring 2002 332 Polyoma Viruses General characteristics Papovaviridae: PA - papilloma; PO - polyoma; VA - vacuolating agent a. 45nm
More informationViral reproductive cycle
Lecture 29: Viruses Lecture outline 11/11/05 Types of viruses Bacteriophage Lytic and lysogenic life cycles viruses viruses Influenza Prions Mad cow disease 0.5 µm Figure 18.4 Viral structure of capsid
More informationDealing with Post-market Issues: PCV Case Study
Dealing with Post-market Issues: PCV Case Study CASE STUDY: Adventitious agent in raw material ISSUE: Presence of porcine circovirus (PCV-1) DNA detected in marketed rotavirus vaccine by an independent
More informationEbola Virus Introduction
Ebola Ebola Virus Introduction First appeared in Africa 1976 African Hemorrhagic Fever acute, mostly fatal disease causes blood vessel bursting systemic (all organs/tissues) humans and nonhuman primates
More informationStudy of rabies virus by Differential Scanning Calorimetry (DSC)
Study of rabies virus by Differential Scanning Calorimetry (DSC) Frédéric Gréco Analytical Research & Developpement Biochemical & Biophysical Characterization 26 September 2016 1 The rabies virus (RABV)
More informationPicornaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Picornaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Naked icosahedral capsid (T=1) Diameter of 30 nm Genome Linear single-stranded RNA, positive
More informationVirion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
More informationLECTURE topics: 1. Immunology. 2. Emerging Pathogens
LECTURE 23 2 topics: 1. Immunology 2. Emerging Pathogens Benefits of the Normal Flora: 1. Protect us from colonization by other bacteria and fungi (competitive exclusion). 2. Many synthesize vitamins,
More informationSina Bavari, Ph.D. US Army Medical Research Institute of Infectious Diseases (USAMRIID) Frederick, MD
Lassa Virus Therapeutics and Target Product Profile Sina Bavari, Ph.D. US Army Medical Research Institute of Infectious Diseases (USAMRIID) Frederick, MD sina.bavari.civ@mail.mil Objectives: 1) How to
More informationRegulation of cell signaling cascades by influenza A virus
The Second International Symposium on Optimization and Systems Biology (OSB 08) Lijiang, China, October 31 November 3, 2008 Copyright 2008 ORSC & APORC, pp. 389 394 Regulation of cell signaling cascades
More informationGastroenteritis and viral infections
Gastroenteritis and viral infections A Large number of viruses are found in the human gut; these include some that are associated with gastroenteritis Rotaviruses Adenoviruses 40/41 Caliciviruses Norwalk-like
More informationReplication Defective Enterovirus Infections: Implications for Type I Diabetes
Replication Defective Enterovirus Infections: Implications for Type I Diabetes N. M. Chapman Department of Pathology & Microbiology University of Nebraska Medical Center Enterovirus Genome and 2 Capsid
More informationChapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
More informationHistory electron microscopes
Viruses History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin word- poison) In the 1930s, after the invention of
More informationA Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
JOURNAL OF VIROLOGY, Jan. 2010, p. 163 175 Vol. 84, No. 1 0022-538X/10/$12.00 doi:10.1128/jvi.01832-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. A Forward Genetic Strategy
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationHIV 101: Fundamentals of HIV Infection
HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able
More informationNature Medicine: doi: /nm.2109
HIV 1 Infects Multipotent Progenitor Cells Causing Cell Death and Establishing Latent Cellular Reservoirs Christoph C. Carter, Adewunmi Onafuwa Nuga, Lucy A. M c Namara, James Riddell IV, Dale Bixby, Michael
More informationTranscriptional regulation in Ebola Virus. The role of VP30
Transcriptional regulation in Ebola Virus The role of VP30 Ebola virus www.ibtimes.com/updated-ebola-outbreak-map-virus-spreads-out-africa-death-toll-tops-4000-1703162 (2018/01/26) First symptoms 2 days
More informationI. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense
I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms Table 2: Innate Immunity: First Lines of Defense Innate Immunity involves nonspecific physical & chemical barriers that are adapted for
More informationOverview of virus life cycle
Overview of virus life cycle cell recognition and internalization release from cells progeny virus assembly membrane breaching nucleus capsid disassembly and genome release replication and translation
More informationSUPPLEMENTAL INFORMATION
SUPPLEMENTAL INFORMATION EXPERIMENTAL PROCEDURES Tryptic digestion protection experiments - PCSK9 with Ab-3D5 (1:1 molar ratio) in 50 mm Tris, ph 8.0, 150 mm NaCl was incubated overnight at 4 o C. The
More informationTranslation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors
Translation Questions? 1) How does poliovirus shutoff eukaryotic translation? 2) If eukaryotic messages are not translated how can poliovirus get its message translated? Host Cell Shutoff 1) Initiation
More informationChapter 14 Part One Biotechnology and Industry: Microbes at Work
Chapter 14 Part One Biotechnology and Industry: Microbes at Work Objectives: After reading Chapter 14, you should understand How biotechnology has resulted in numerous pharmaceutical products to help lessen
More informationChapter 6. Antigen Presentation to T lymphocytes
Chapter 6 Antigen Presentation to T lymphocytes Generation of T-cell Receptor Ligands T cells only recognize Ags displayed on cell surfaces These Ags may be derived from pathogens that replicate within
More informationHS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.
Unit 2, Lesson 2: Teacher s Edition 1 Unit 2: Lesson 2 Influenza and HIV Lesson Questions: o What steps are involved in viral infection and replication? o Why are some kinds of influenza virus more deadly
More informationTest Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas
Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Chapter 04: Antigen Recognition in the Adaptive Immune System Test Bank MULTIPLE CHOICE 1. Most T lymphocytes
More information